Additionally,we assessed the biocompatibility and tumor-targeting properties ofDOX@MSNP-BA-Tf, demonstrating its potential to selectively deliverdrugs to cancer cells while diminishing off-target effects on normalcells. The gene discussed is TF; the disease is cancer.